Who
Vinay Shah
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, Adial Pharmaceuticals; Chief Financial Officer, Virpax Pharmaceuticals; Chief Financial Officer, Aravive.
In numbers
- Trades disclosed
- 18
- Buys
- 2
- Sells
- 0
- Bought
- $51K
- Sold
- $0
- Companies
- 3
- Companies where not an officer
- 0
- First trade
- 12 Oct 2018
- Last trade
- 7 Apr 2026
- Last filed
- 9 Apr 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 7 Apr 2026filed 9 Apr 2026 | ADIL Adial PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —17,325 at $0.00 | filing |
| 7 Apr 2026filed 9 Apr 2026 | ADIL Adial PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —17,325 at $0.00 | filing |
| 29 May 2025filed 2 Jun 2025 | ADIL Adial Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —9,000 at $0.00 | filing |
| 16 Nov 2024filed 18 Nov 2024 | ADIL Adial Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
| 29 Jan 2024filed 31 Jan 2024 | Virpax Pharmaceuticalsoption or derivative | SEC FORM 4 Code A | —112,000 at $0.00 | filing |
| 20 Jun 2023filed 16 Aug 2023 | Virpax Pharmaceuticalsoption or derivative | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 20 Jun 2023filed 21 Jun 2023 | Virpax Pharmaceuticalsoption or derivative | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 24 Jan 2022filed 25 Jan 2022 | Araviveoption or derivative | SEC FORM 4 Code A | —175,000 at $0.00 | filing |
| 29 Jun 2021filed 29 Jun 2021 | Aravive | SEC FORM 4 Bought | $5,3101,000 at $5.31 | filing |
| 25 Jan 2021filed 26 Jan 2021 | Araviveoption or derivative | SEC FORM 4 Code A | —60,000 at $0.00 | filing |
| 4 Dec 2020filed 7 Dec 2020 | Aravive | SEC FORM 4 Bought | $46K8,000 at $5.76 | filing |
| 22 Jan 2020filed 24 Jan 2020 | Araviveoption or derivative | SEC FORM 4 Code A | —34,826 at $0.00 | filing |
| 28 Feb 2019filed 4 Mar 2019 | Araviveoption or derivative | SEC FORM 4 Code A | —38,000 at $0.00 | filing |
| 12 Oct 2018filed 16 Oct 2018 | Araviveoption or derivative | SEC FORM 4 Code A | —19,380 | filing |
| 12 Oct 2018filed 16 Oct 2018 | Araviveoption or derivative | SEC FORM 4 Code A | —38,001 | filing |
| 12 Oct 2018filed 16 Oct 2018 | Araviveoption or derivative | SEC FORM 4 Code A | —19,000 | filing |
| 12 Oct 2018filed 16 Oct 2018 | Araviveoption or derivative | SEC FORM 4 Code A | —19,000 | filing |
| 12 Oct 2018filed 16 Oct 2018 | Aravive | SEC FORM 4 Code A | —178,606 | filing |
News
No headline names them, or the companies they trade most, lately.